Application of sequential analysis to Evans blue-carrageenan-induced pleural effusion for screening compounds for anti-inflammatory activity.
D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002351:Carrageenan; D004396:Coloring Agents; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005938:Glucocorticoids / Q000627:therapeutic use; D006052:Gold Sodium Thiomalate / Q000627:therapeutic use; D010996:Pleural Effusion / Q000139:chemically induced* / Q000188:drug therapy; D051381:Rats; D013256:Steroids / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004396:Coloring Agents; D005938:Glucocorticoids; D013256:Steroids; D006052:Gold Sodium Thiomalate; D002351:Carrageenan; D001241:Aspirin